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ALTHOUGH it has been shown that killer cell immu-
noglobulin-like receptors (KIRs) on peripheral lym-
phocytes are upregulated by interleukin-2 (IL-2),
which activates natural killer (NK) activity, it has
not been demonstrated whether the expression of
KIRs is related to NK activity. Therefore, we investi-
gated the association between the KIR expression on
lymphocytes and NK activity. CD158a/b expression
on lymphocytes obtained from 37 subjects was
analyzed using flow cytometry. Simultaneously, NK
activity was measured each sample using a
51Cr-
release assay. Additionally, lymphocytes were cul-
tured in RPMI 1640 medium with or without IL-2 for
48 h, and then their CD158a/b expression and NK
activity was analyzed. CD158a/b expression was
significantly correlated with NK activity. Especially,
the percentage of CD16 /CD158a / and CD8 /
CD158a/b / cells in lymphocytes showed a highly
significant correlation with NK activity. However,
analysis of CD8 / and CD16 / cells revealed that
there was only a significant correlation between the
percentage of CD8 /CD158a / cells among only
CD8 / cells and NK activity. The upregulation of
CD16 /CD158a //b / cells in response to IL-2 tended
to be related to the increase of NK activity, but the
relationship was not significant. In conclusion, the
level of KIR expression was correlated with NK
activity, and IL-2 treatment resulted in an increase
of NK activity as well as KIR expression, suggesting
that upregulation of KIRs enhances the ability to sort
target cells, such as virus-infected cells from unin-
fected cells, according to major histocompatibility
complex class I expression.
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Introduction
Natural killer (NK) cells are a discrete population of
lymphocytes characterized in humans by the expres-
sion of CD16 and CD56 cell surface antigens.
1 NK
cells are most noted for their in vitro ability to
spontaneously lyse transformed or virus-infected and
some normal cells, and are also potent producers of
lymphokines, predominantly interferon-g and tumor
necrosis factor-a. Given their rapid activation during
an immune response and their dual role in cell-
mediated cytotoxicity and lymphokine production,
NK cells are considered an important component of
natural resistance, active as a first line of defense
against infectious agents.
Although the exact mechanisms that NK cells
utilize to recognize and lyse target cells have
remained poorly understood, the molecular cloning
of novel NK receptors was achieved in 1995,
24 and it
has subsequently been shown that these receptors,
which are now called killer cell immunoglobulin-like
receptors (KIRs), transmit positive and/or negative
signals.
5,6 It is now widely accepted that the expres-
sion of KIRs is involved in the cytolytic function of
NK cells, as demonstrated by a number of studies
focusing on these receptors.
7
We previously reported that the expression of both
KIR2DL1 and KIR2DS1 (CD158a), and KIR2DL2,
KIR2DL3 and KIR2DS2 (CD158b) on lymphocytes is
upregulated by interleukin (IL)-2 but not by inter-
feron-g or IL-4, although IL-2 enhances the cytotoxi-
city of NK cells.
8 It has been speculated that the
upregulation of KIRs by IL-2 results in enhanced
ability to sort target cells such as virus-infected cells
from uninfected cells according to major histocom-
patibility complex (MHC) class I expression. How-
ever, there has been no report of any investigation
demonstrating an association between NK cytolytic
activity and KIRs expression. In this study, we
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117examined their relationship using peripheral blood
lymphocytes in humans.
Methods
Reagents
Fluorescein isothiocyanate (FITC)-conjugated anti-
human CD8, FITC-anti-human CD16, phycoerythrin
(PE)-conjugated anti-human CD158a (EB6) and PE-
conjugated anti-human CD158b (GL183) were pur-
chased from Immunotech (Marseille, France). Re-
combinant human IL-2 was obtained from
Pharmabiotechnology (Hanover, Germany).
Cells
Peripheral blood mononuclear cells obtained from 37
volunteers (24 females and 13 males; age (mean9 /
standard deviation), 66.39 /25.4 years; range, 25/86
years) were separated from heparinized blood by
Lymphoprep (Nyegaard, Oslo, Norway) gradient
cenfugation.
9 Each peripheral blood mononuclear
cell sample was a incubated in culture dish in a
humidified 5% CO2/95% air atmosphere at 378Cf o r
60 min. After the incubation, non-adherent cells were
collected. These cell suspensions were washed twice
in phosphate-buffered saline (PBS).
Cell culture
One million cells were cultured in RPMI 1640
medium supplemented with 10% fetal calf serum
(Biological Industries, Israel) in tissue culture dishes
(Becton Dickinson, Flanklin, NJ, USA). The cell
cultures were incubated in medium only or medium
containing IL-2 at 100 U/ml in a humidified 5% CO2/
95% air atmosphere at 378C for 48 h. After each
incubation, cells were collected and their surface
antigens were analyzed using flow cytometry (Epics
XL; Beckman Coulter, Marseille, France). Simulta-
neously, the NK activity in each sample was mea-
sured using a
51Cr-release assay. Each experiment
was carried out in duplicate.
Cell phenotype
Surface phenotyping was carried out using a two-
color immunofluorescence staining technique, with
isotype-specific mouse anti-human antibody conju-
gated with either FITC or PE.
10 Each sample of
stained cells was suspended in 0.5 ml of PBS and
analyzed by flow cytometry. Lymphocyte subsets
were identified by gating analysis and fluorescence
profiles were obtained for 10,000 cells of each
sample. Negative controls for each experiment were
performed with FITC-labeled and PE-labeled mouse
immunoglobulin G.
NK cytolytic activity
NK activity was assessed against K562, a myeloge-
neous leukemia cell line, in a 3 h
51Cr-release assay as
described previously. The effecter cells were mixed
with labeled target cells at various cell concentrations
to give effecter to target ratios of 20:1 or 10:1.
Duplicate samples were prepared for each ratio.
The supernatants were withdrawn after a 4 h
incubation period, and the
51Cr released from lysed
targets was quantitated in a gamma counter (Packard
Instrument Co., Boston, MA, USA). Incubation of
targets with medium or saponin (7 mg/ml) and
ethylenediamine tetraacetic acid (0.1 mg/ml) was
used to determine spontaneous and maximal release,
respectively. The percent cytotoxicity was calculated
by the formula: (cpm of effecter cells / cpm of
spontaneous release)/(cpm of maximal release /
cpm of spontaneous release)/100.
Statistical analysis
Data are expressed as mean (standard deviation)
values. All data were collected in a computer
database and analyzed using the StatView-J 4.02
program (Abacus Concept, Berkeley, CA, USA).
Spearman rank correlation analysis was performed
between each part of NK activity and KIR expression.
For all statistical tests, correlations were regarded as
statistically significant if pB/0.05.
Results
The relationship between the percentage of
CD158a / or CD158b / cells in lymphocytes and
NK cytolytic activity
There was no relationship between the expression of
CD16 and NK cytotoxicity (Table 1). In contrast, the
expression of CD158a or CD158b correlated with the
NK cytolytic activity significantly (Table 1). The
correlation of CD158a expression with NK cytotoxi-
city is shown in Fig. 1.
The relationship between the percentage of
CD8 /CD158a //b / or CD16 /CD158a //b /
cells in lymphocytes and NK cytolytic activity
There was a significant relationship between the
percentage of CD8 /CD158a //b / cells and NK
cytolytic activity (Table 1). Similarly, the percentage
of CD16 /CD158b / cells tended to be correlated
with NK cytolytic activity, although the correlation
was not significant (Table 1).
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CD158a/b / cells in CD8 / or CD16 / cells and
NK activity
To investigate the significance of the KIR expression
on CD8 / or CD16 / cells, we further analyzed the
association between the percentage of CD158a/b /
cells in CD8 / or CD16 / cells and NK activity. There
was a tendency toward a correlation between the
percentage of CD8 /CD158a / cells in CD8 / cells
and NK cytolytic activity. However, we could not find
a significant correlation between the percentage of
CD8 /CD158b / cells/CD8 / cells, CD16 /
CD158a / cells/CD16 / cells or CD16 /CD158b /
cells/CD16 / cells, and NK cytotoxicity (Table 1).
The change of CD158a/b expression and NK
activity when lymphocytes are treated with IL-2
We assessed the CD158a/b expression and NK
cytolytic activity after treatment of eight donors with
IL-2. NK cytotoxicity increased by treatment of IL-2 as
previously shown
8,11 (Fig. 2A). Simultaneously, the
percentage of CD158a / and CD158b / cells in-
creased (Fig. 2B). In addition, the percentage of
CD8 /CD158a //b / cells and CD16 /CD158a //
b / cells also increased in parallel with the increase
of NK cytotoxicity (Fig. 2B). The increases of the
CD158a //b / cell population and NK cytolytic
activity by treatment with IL-2 were dose dependent
from 10 to 200 U/ml (data not shown).
Discussion
In this study, we first showed that NK cytolytic
activity correlates with the expression of KIRs recog-
nized by CD158a/b in humans. Second, we showed
that upregulation of the KIR expression was accom-
panied by an increase of NK cytotoxicity when
lymphocytes were incubated with medium plus IL-
2. The present findings support the speculation
described earlier. Namely, when the cytolytic activity
increases, the expression of KIRs also increased.
Alternatively, the percentage of CD16 /CD158b /
cells did not correlate with NK cytolytic activity,
although the percentage of CD16 /CD158a / and
CD8 /CD158a //b / cells correlated with it in our
study. NK cytolytic activity is dependent on the
signaling balance of KIRs, activating receptors and
the expression of their ligands. Therefore, there is a
not always a relationship between the NK cytolytic
activity and the proportion of KIR-positive cells in the
cross-sectional analysis. In contrast, the percentage of
each cell population is related to the NK cytolytic
activity after treatment with IL-2, indicating that the
expression of KIRs is upregulated when NK activity
increases. These findings are in accord with recently
published data showing that downregulation of KIRs
is accompanied by a decrease of natural killing
activity.
12 However, it is unclear whether the upre-
gulation of KIRs occurs before or after enhancement
of NK activity.
Analysis of the percentage of KIR-expressing cells
among CD8 / or CD16 / cells revealed that the
percentage of CD158a expression on CD8 / cells, but
not on CD16 / cells, correlated with NK activity. We
cannot yet explain these phenomena from the
Table 1. Correlation of NK cytolytic activity with several cell surface antigens
NK cytolytic activity V.S.** Probability* Linear regression coefficient
CD16 0.086 0.295
CD158a 0.010 0.424
CD158b 0.032 0.362
CD8CD158a 0.008 0.432
CD8CD158b 0.006 0.458
CD16CD158a 0.018 0.398
CD16 CD158b 0.130 0.257
CD8 /CD158a / cell/CD8 / cell 0.026 0.375
CD8 /CD158b / cell/CD8 / cell 0.117 0.270
CD16 /CD158a / cell/CD16 / cell 0.163 0.241
CD16 /CD158b / cell/CD16 / cell 0.790 0.047
*If probabilityB/0.05, correlations are regarded as ststistically significant.
**V.S./versus.
FIG. 1. The correlation of CD158a / cells with natural killing
activity is shown. P/0.0099, r/0.424.
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expression of KIRs on CD8 / cells is more important
functionally than inhibitory receptors on CD16 /
cells. Although the function of KIRs in CD8 / T cells
is still obscure, these KIRs probably prevent auto-
aggression by cytotoxic T cells specific for self-
antigens.
13,14 In T cells, the expression of the activat-
ing receptors such as TCR and CD2, and the MHC-
restricted killing activity, are not affected by KIR
downregulation.
15 Thus, the only known fail-safe
system to escape attack by cytotoxic T cells is the
inactivation by negative signals from KIRs on T cells.
Indeed, in NK cells, activating receptors were found
to be decreased by KIR/MHC class I interactions, and
this receptor downregulation was correlated with a
deficiency in the NK activity as well as CD16-
mediated killing activity.
12,16 These phenomena ap-
peared to be specific to NK cells.
KIRs recognized by CD158a/b consist of two kinds
of receptors.
17,18 CD158a reacts with KIR2DL1 (in-
hibitory receptor (IR)) and KIR2DS1 (activating
receptor (AR)), and CD158b reacts with KIR2DL2,
KIR2DL3 (IR) and KIR2DS2 (AR). CD158a/b mono-
clonal antibodies (mAb) cannot distinguish between
these receptors. Furthermore, the ligands that react
with AR have been identified as ligands that react
with IR and, importantly, the CD158b mAb we used
bound equally to the AR and IR,
19 making it difficult
to explain NK cell regulation. To date, it has been
considered that the activating signal can be over-
ridden by a dominant-negative signal from IR when
IR interacts with its ligand on the target cell, although
AR, when occupied, triggers lysis of the target cell
being recognized.
20,21 These insights led us to spec-
ulate that KIRs increase as part of the defense system
of non-infected cells when NK cells are activated by
viral infection, although other activating receptors
such as CD69
22 and 2B4
23 might be upregulated.
However, several critical questions remain. The
importance of AR upregulation parallel to IR upre-
gulation is still not clear in NK cell activation.
Recently, a biphasic response of NK cells expressing
both AR and IR has been demonstrated.
24 High
concentrations of CD158b mAb transmitted inhibitory
signals to NK cells, whereas low concentrations
transmitted activating signals.
24 Warren et al. specu-
lated that there is a fail-safe mechanism for activating
NK cells if other NK cell-activating receptors or target
FIG. 2. The change of CD158a/b expression and NK activity when lymphocytes are treated with medium alone or medium
containing IL-2 at 100 U/ml. Eight of 35 donors were assessed for CD158a/b expression and NK cytolytic activity. (A) NK
cytolytic activity in bars representing medium alone and medium with IL-2. (B) Six lines presenting the percentage increase of
subsequent CD cells. The percentage of each CD cell was increased signiﬁcantly by the treatment of IL-2. The change of each
CD cell was in parallel to the increase of NK activity.
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when histocompatibility antigen (HLA) concentra-
tions on target cells are below that capable of
inhibiting NK cell function. In our study, NK cytolytic
activity correlated with the expression of CD158a/b-
recognizing receptors. A possible rationale for the
upregulation of both IR and AR during the course of
viral infection or neoplastic disease is that NK cells
are capable of lysing cells expressing low levels of
HLA in early stages of diseases independently of
other activating receptors, and NK cells are also
inactivated by negative signals from IR if activating
receptor-expressing NK cells encounter normal cells
on which HLA molecules are highly expressed.
Therefore, we speculate that it is beneficial for the
bio-defense system to upregulate the expression of
KIRs when NK cells acquire enhanced cytotoxic
activity. Recently, Huard et al. reported that KIR
downregulation on NK cells is associated with the
downregulation of activating receptors such as 2B4 as
well as with a lack of cell responsiveness12. There-
after, several safety mechanisms may function to
protect normal HLA-expressing cells.
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